首页> 外文会议>World biomaterials congress >Photochemical tussue penetration via photosensitizer for the efficient penetration of drug into tumor tissue
【24h】

Photochemical tussue penetration via photosensitizer for the efficient penetration of drug into tumor tissue

机译:光晶牙膏渗透通过光敏剂,以有效的药物渗透到肿瘤组织中

获取原文

摘要

Introduction: A non-vascular drug eluting stent (DES) is a biomedical device that is implanted in the gastrointestinal (GI) tract for stabilizing the flow of body fluids when obstructive symptoms are shown due to tumor growth. Recently, gemcitabine (GEM) eluting membrane covered stents have been developed and highlighted because of the strong therapeutic effect of GEM in Gl tumor therapy. However, GEM has a low tissue penetration efficiency (PE%) in the Gl tract because of its hydrophilicity and the epithelial barrier function. For this reason, some cells of a GEM treated tumor can continue to proliferate and allow tumor growth. We believe that an alteration of the epithelial layer is required for improving drug penetration. Materials and Methods: To prepare the membranes, 200 mL of the above mixed solution(Gemcitabine(GEM), Photosensitizer(PS), Polyurethane(PU)) was poured into the polytetrafluorethylene (Teflon) mold and dried. The surface morphologies of each membrane were observed with Field emission-scanning electron microscopy (FE-SEM). To confirm the drug release behaviors, GEM-PU (PS absent membrane) and PS-GEM-PU were placed into conical tubes, and phosphate buffer saline was added. To confirm the generation of singlet oxygen, PS-GEM-PU was incubated in PBS for 0,1 or 2 weeks. To confirm the PE% enhancing mechanism, CT-26 cells were cultured in a 6-well plate and Chang cells were cultured . To visualize the tissue penetration of the hydrophilic molecule, fluorescein was loaded instead of GEM in the drug eluting membrane. To evaluate in vivo tumor growth inhibition activity, CT-26 bearing Balb/c nude mice were used. Results: PS was uniformly spread in the membrane. GEM was located in the nearby abluninal side of the membrane. The releasing of GEM was not influenced by the addition of PS. Also, under the light exposure, the singlet oxygen was generated by PS at the membrane surface for 2 weeks. The PE% of GEM from PS-GEM with light was 30% higher than the others of in vitro penetration test. To visualize the tissue penetration test of the hydrophilic molecule, the intensity of the penetrated FITC in the PS-fluorescein with light group increased by approximately 200% compared to the others. To evaluate the tumor growth inhibition efficiency, the tumor with GEM-PU with or without light and PS-GEM-PU without light grew exponentially; almost 3 times larger tumor volumes were measured than in the PS-GEM-PU group. In TUNEL assay, apoptotic cells were detected at the nearby tumor-membrane interface in the case of GEM-PU with or without light and PS-GEM-PU without light. Discussion: To improve the tissue penetration efficiency of hydrophilic-drugs in non-vascular drug eluting stents(DES), we designed photochemical tissue penetration invested DES. Consequentially, tumor growth, when implanted with PS-GEM-PU, was effectively inhibited without significant side effects. Based on these results, we believe that the photochemical tissue penetration-DES system has great potential for improving the therapeutic effect of conventional DES. Conclusion: PS-GEM-PU was designed and prepared to increase both the tissue penetration and the therapeutic efficacy of a GEM loaded DES. In this study, we overcame this barrier using a PS-DES membrane. Thus, the membrane has a higher therapeutic effect than a conventional GEM eluting membrane. To improve the therapeutic potency of PS-DES system, further experiments were required to optimize drug content in DES membrane.
机译:介绍:非血管药物洗脱支架(DES)是一种生物医学装置,其植入胃肠道(GI)道以稳定当由于肿瘤生长而显示阻塞性症状时体液流动。最近,由于宝石在GL肿瘤治疗中的强治疗效果,吉西他滨(宝石)已经开发并突出显示了膜覆盖的支架。然而,由于其亲水性和上皮屏障功能,GEM具有低组织穿透效率(PE%)。因此,Gem处理的肿瘤的一些细胞可以继续促进并允许肿瘤生长。我们认为改善上皮层的改变来改善药物渗透。材料和方法:为了制备膜,将200ml上述混合溶液(吉西他滨(GEM),光敏剂(PS),将聚氨酯(PU))倒入聚四氟乙烯(Teflon)模具中并干燥。用场发射扫描电子显微镜(Fe-SEM)观察每个膜的表面形态。为了确认药物释放行为,将GEM-PU(PS非活动膜)和PS-GEM-PU置于锥形管中,并加入磷酸盐缓冲盐水。为了确认单次氧的产生,PS-GEM-PU在PBS中孵育0,1或2周。为了确认PE%增强机制,CT-26细胞在6孔板中培养,培养COLC细胞。为了可视化亲水分子的组织渗透,荧光素被加载而不是药物洗脱膜中的绒毛。为了评价体内肿瘤生长抑制活性,使用CT-26轴承BALB / C裸鼠。结果:PS均匀地涂布在膜中。宝石位于附近的膜的Allunnalinal侧面。宝石的释放不受PS的添加影响。而且,在曝光下,单向氧通过PS在膜表面上产生2周。来自PS-Gem的宝石PE%比在体外穿透试验中的其他比例高30%。为了可视化亲水分子的组织渗透试验,与其他具有轻基团的PS-荧光素中的穿透式FITC的强度增加约200%。为了评估肿瘤生长抑制效率,具有或没有光和PS-GEM-PU的GEM-PU的肿瘤呈指数增长;测量肿瘤体积大于PS-Gem-PU组的几乎3倍。在TUNEL测定中,在具有或没有光和PS-GEM-PU的GEM-PU的情况下在附近的肿瘤膜界面中检测到凋亡细胞。讨论:改善非血管药物洗脱支架中亲水药物的组织渗透效率(DES),我们设计了光化学组织渗透投资的DES。因此,有效地抑制了当植入PS-Gem-PU时的肿瘤生长而无明显副作用。基于这些结果,我们认为光化学组织渗透-DES系统具有改善常规DES治疗效果的巨大潜力。结论:PS-GEM-PU设计并准备增加组织渗透和宝石装载DES的治疗效果。在这项研究中,我们使用PS-DES膜克服该屏障。因此,膜具有比常规宝石洗脱膜更高的治疗效果。为了改善PS-DES系统的治疗效力,需要进一步的实验来优化DES膜中的药物含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号